Moderate to Severe Atopic Dermatitis Clinical Trial
Tennessee Clinical Research is conducting a new clinical study evaluating potential options for moderate to severe atopic dermatitis patients with a history of inadequate response to past medications.
Study Overview
Who Qualifies? Patients with moderate to severe atopic dermatitis (affecting 10% or more of body surface area, who have shown inadequate response to topical treatments or for whom topical treatments are inadvisable
Study Duration: 22 visits over 2 years
Study Purpose: This study is evaluating the efficacy of investigational drug APG777
Clinicaltrials.gov ID: NCT06395948
Site Location
Need help? Have questions?
Contact Us
Call or text: (805) 705-5872
Email: contact@clinicallymedia.com
